In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported

Tauangtham Anekpuritanang; Matthew M. Klairmont; Joel Gradowski; Kohei Hagiwara; Nathanael G. Bailey; Pranil Chandra; Yiwei Liu; Heather L. Mulder; John Easton; Jinghui Zhang; Michael G. Martin; Anna B. Owczarczyk; Jennifer B. Dunlap; Guang Fan; Richard D. Press; Philipp W. Raess

doi:10.1182/bloodadvances.2021004983

In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported

Tauangtham Anekpuritanang, Matthew M. Klairmont, Joel Gradowski, Kohei Hagiwara, Nathanael G. Bailey, Pranil Chandra, Yiwei Liu, Heather L. Mulder, John Easton, Jinghui Zhang, Michael G. Martin, Anna B. Owczarczyk, Jennifer B. Dunlap, Guang Fan, Richard D. Press, Philipp W. Raess

Research output: Contribution to journal › Letter › peer-review

3 Scopus citations

Original language	English (US)
Pages (from-to)	5057-5059
Number of pages	3
Journal	Blood Advances
Volume	5
DOIs	https://doi.org/10.1182/bloodadvances.2021004983
State	Published - Dec 14 2021

ASJC Scopus subject areas

Hematology

Access to Document

10.1182/bloodadvances.2021004983

Cite this

Anekpuritanang, T., Klairmont, M. M., Gradowski, J., Hagiwara, K., Bailey, N. G., Chandra, P., Liu, Y., Mulder, H. L., Easton, J., Zhang, J., Martin, M. G., Owczarczyk, A. B., Dunlap, J. B., Fan, G., Press, R. D., & Raess, P. W. (2021). In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported. Blood Advances, 5, 5057-5059. https://doi.org/10.1182/bloodadvances.2021004983

Anekpuritanang, T, Klairmont, MM, Gradowski, J, Hagiwara, K, Bailey, NG, Chandra, P, Liu, Y, Mulder, HL, Easton, J, Zhang, J, Martin, MG, Owczarczyk, AB, Dunlap, JB , Fan, G , Press, RD & Raess, PW 2021, 'In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported', Blood Advances, vol. 5, pp. 5057-5059. https://doi.org/10.1182/bloodadvances.2021004983

@article{d0b7bbead6d848858d940e5f133071eb,

title = "In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported",

author = "Tauangtham Anekpuritanang and Klairmont, {Matthew M.} and Joel Gradowski and Kohei Hagiwara and Bailey, {Nathanael G.} and Pranil Chandra and Yiwei Liu and Mulder, {Heather L.} and John Easton and Jinghui Zhang and Martin, {Michael G.} and Owczarczyk, {Anna B.} and Dunlap, {Jennifer B.} and Guang Fan and Press, {Richard D.} and Raess, {Philipp W.}",

note = "Funding Information: Acknowledgments: Biostatistics support was provided by the Biostatistics Shared Resource, Knight Cancer Institute (National Institutes of Health National Cancer Institute P30CA069533) (E.L. and B.P.) Contribution: T.A. designed experiments, analyzed data, and wrote the manuscript; M.M.K. designed experiments, analyzed data, and edited the manuscript; J.G., P.C., and A.B.O. contributed cases; K.H. analyzed data and edited the manuscript; N.G.B. contributed cases and edited the manuscript; Y.L., H.L.M., J.E., and J.Z. analyzed data; M.G.M. designed experiments, reviewed the manuscript, and provided funding; J.B.D., G.F., and R.D.P. analyzed data and edited the manuscript; and P.W.R. designed experiments, analyzed data, and wrote the manuscript.",

year = "2021",

month = dec,

day = "14",

doi = "10.1182/bloodadvances.2021004983",

language = "English (US)",

volume = "5",

pages = "5057--5059",

journal = "Blood Advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

}

TY - JOUR

T1 - In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported

AU - Anekpuritanang, Tauangtham

AU - Klairmont, Matthew M.

AU - Gradowski, Joel

AU - Hagiwara, Kohei

AU - Bailey, Nathanael G.

AU - Chandra, Pranil

AU - Liu, Yiwei

AU - Mulder, Heather L.

AU - Easton, John

AU - Zhang, Jinghui

AU - Martin, Michael G.

AU - Owczarczyk, Anna B.

AU - Dunlap, Jennifer B.

AU - Fan, Guang

AU - Press, Richard D.

AU - Raess, Philipp W.

N1 - Funding Information: Acknowledgments: Biostatistics support was provided by the Biostatistics Shared Resource, Knight Cancer Institute (National Institutes of Health National Cancer Institute P30CA069533) (E.L. and B.P.) Contribution: T.A. designed experiments, analyzed data, and wrote the manuscript; M.M.K. designed experiments, analyzed data, and edited the manuscript; J.G., P.C., and A.B.O. contributed cases; K.H. analyzed data and edited the manuscript; N.G.B. contributed cases and edited the manuscript; Y.L., H.L.M., J.E., and J.Z. analyzed data; M.G.M. designed experiments, reviewed the manuscript, and provided funding; J.B.D., G.F., and R.D.P. analyzed data and edited the manuscript; and P.W.R. designed experiments, analyzed data, and wrote the manuscript.

PY - 2021/12/14

Y1 - 2021/12/14

UR - http://www.scopus.com/inward/record.url?scp=85121731933&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85121731933&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2021004983

DO - 10.1182/bloodadvances.2021004983

M3 - Letter

C2 - 34559205

AN - SCOPUS:85121731933

SN - 2473-9529

VL - 5

SP - 5057

EP - 5059

JO - Blood Advances

JF - Blood Advances

ER -

In a multi-institutional cohort of myeloid sarcomas, NFE2 mutation prevalence is lower than previously reported

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this